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Abstract
The absence of circadian zeitgebers in the social environment causes circadian misalignment, which
is often associated with sleep disturbances. Circadian misalignment, defined as a mismatch between
the sleep-wake cycle and the timing of the circadian system, can occur either because of inadequate
exposure to the light-dark cycle, the most important synchronizer of the circadian system, or
reduction in light transmission resulting from ophthalmic diseases (e.g., senile miosis, cataract,
diabetic retinopathy, macular degeneration, retinitis pigmentosa, and glaucoma). We propose that
glaucoma may be the primary ocular disease that directly compromises photic input to the
circadian time-keeping system because of inherent ganglion cell death. Glaucomatous damage to
the ganglion cell layer might be particularly harmful to melanopsin. According to histologic and
circadian data, a subset of intrinsically photoresponsive retinal ganglion cells, expressing melanopsin
and cryptochromes, entrain the endogenous circadian system via transduction of photic input to
the thalamus, projecting either to the suprachiasmatic nucleus or the lateral geniculate nucleus.
Glaucoma provides a unique opportunity to explore whether in fact light transmission to the
circadian system is compromised as a result of ganglion cell loss.
Background
Light in human physiology
Numerous experimental studies have convincingly shown
that light is the most important synchronizer of circadian
rhythms [1]. On a daily basis, light sets and resets the tim-
ing of the circadian time-keeping system, to ensure its
proper functioning. Consistent with established phase
response curves, light exposure early in the morning resets
the circadian system to adjust for its propensity to phase-
delay, and light exposure in the evening is necessary to
adjust for phase-advances in the master clock [2-6].
In the absence of the entraining effects of the light-dark
cycle, the circadian system free-runs [7]. According to
time-isolation studies, the circadian system can gradually
shift and may even become completely desynchronized
with respect to external environmental cycles [7,8]. Thus,
failure to achieve such necessary adjustments in the tim-
ing of the circadian system, either because of deprivation
of light cues, knowledge of time, or societal pressures
[9,10], could lead to circadian misalignment (see below),
which could engender circadian disorders. Paradoxically,
the ability of organisms to free-run is considered an
advantage, as it allows them to maintain a stable phase
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relation with the environmental cycles and/or to adapt to
seasonal variations in day length [11].
Ocular pathology and light resistance
Research conducted with visually intact adults has shown
that the photosensory brightness-sensing system provides
direct photic input to the suprachiasmatic nuclei (SCN,
the master circadian clock in mammals), using pathways
that are distinct from the standard retinal radiations to the
visual system [12-14]. Studies distinguish between two
entraining photic pathways. The primary pathway uses
the retinohypothalamic tract that transmits photic cues to
the SCN and the pineal gland [15,16]. The secondary
pathway referred to as the geniculohypothalamic tract
stems from the intergeniculate leaflet of the lateral
hypothalamus [17-19].
Much of the literature in human chronobiology has
focused on studies of aging volunteers in good health. Lit-
tle has been done to study effects of age-related anatomic
and physiologic changes on the photic system, but it is
known that important structural SCN alterations as well
retinal diseases affect circadian rhythmicity. Research has
demonstrated both cellular and structural alterations of
the SCN [20,21]. Indeed, neuropathologic studies have
revealed selective deterioration of the SCN cell group (i.e.,
arginine-vasopressin cells) [20,22,23]. Animal studies
show age-associated reduction in the amplitude of the
rhythm of mRNAs for arginine-vasopressin [24]. In addi-
tion, investigations of the expression of mPer1 mRNA and
mPer2 mRNA suggest young mice have a stable and well-
synchronized circadian rest-activity cycle, whereas older
mice display rhythms that are less stable and phase-
advanced [25]. These results are consistent with the find-
ing that hormonal secretions (e.g., melatonin, prolactin,
TSH, and cortisol) of older adults occur earlier in the day
than for younger persons [26-29]. Similarly, body temper-
ature has also shown age-related phase advances [30,31].
Research also shows that a number of ophthalmic factors
are associated with age-related reduction in light transmis-
sion. One such factor is senile miosis, a condition charac-
terized by a reduction in the diameter of the pupil
reducing light transmission to the retina [32]. Opacifica-
tion of the ocular lens can reduce light transmission by as
much as 99%, at which point cataract surgery may
become necessary [33]. The finding that loss of retinal
ganglion cells occurs in glaucoma [34] may yet be the
most important observation concerning circadian human
physiology. In severe cases, patients with glaucoma can
lose up to 95% of their retinal ganglion cells [35,36]. Gan-
glion cell death may have direct and adverse effects on the
circadian timing system (see 'Glaucoma and Melanopsin
Cells').
Age-related reduction in light responsivity has also been
demonstrated in animal research. One study showed that
circadian phase responsivity to light may be 20 times as
great in young hamsters as in old hamsters [37]. Further-
more, older rats seem to need brighter light in order to
achieve a desired amplitude of the activity rhythm
[38,39]. It is not entirely clear how age-related ocular and
neural changes compromise the effectiveness of ambient
illumination in maintaining circadian entrainment in
humans. Based on observational data from the laboratory
and in the home environment, older adults exhibit
advanced circadian phases of sleep, cortisol, and aMT6s
onset [29]. More research is needed to ascertain whether
in fact older individuals develop light resistance because
of ocular/optic diseases. It's also important to determine
the best light stimulus for optimal circadian entrainment
among adults with ophthalmic diseases.
The concept of light resistance refers to a reduction in the
expected physiologic or behavioral response to light expo-
sure. Older adults might be particularly vulnerable
because of a greater likelihood of experiencing visual
impairment [40,41]. Light resistance could also be
defined as a reduction in light suppression of melatonin.
It is hypothesized that individuals showing light resist-
ance would require a greater amount of illumination to
normalize circadian synchronization, thereby improving
circadian-related functions. An average amount of illumi-
nation, as normally observed in the home environment of
the elderly [42-44] would, therefore, be inadequate to pre-
vent circadian misalignment [5,8].
It is noteworthy that a study of experimental bright light
treatments showed improvement of circadian rhythm
functions only among patients with intact vision, but not
among visually impaired patients [45]. Investigators at the
University of California, San Diego found that some older
adults showed resistance to light treatments, and as many
as 30% of them were characterized by circadian parame-
ters outside the range of healthy young adults [46]. Work
done by the same investigative group also revealed that
one hour of bright green light (1,200 Lux) had no signifi-
cant antidepressant effect in depressed elders [47]. Nega-
tive findings regarding benefits of bright light treatments
might be explained by inadequate compensation for defi-
cits in the peripheral visual system associated with aging.
Failure to achieve desirable results in studies of light ther-
apy might also be due to inadequate methodological con-
trol for ophthalmic diseases. A recent study conducted
among adults ages 50–85 years showed that adjusting for
effects of ophthalmic factors reduced the magnitude and
strength of the correlations between ambient illumina-
tion level and mood [48]. Evidence also suggests that the
timing of endogenous melatonin is earlier among individ-Journal of Circadian Rhythms 2008, 6:1 http://www.jcircadianrhythms.com/content/6/1/1
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uals with elevated intraocular pressure and large optic
cup-to-disk ratios, two common indices of glaucoma [49].
Ophthalmic diseases and circadian rhythms
No conclusive evidence supports a cause-and-effect rela-
tionship between varying ophthalmic diseases and circa-
dian-rhythm functions, although it is well established that
in cases where blindness ensues the affected individual
experiences poorly entrained circadian rhythms, along
with sleep disturbances and depressed moods [40,50,51].
Ophthalmic diseases that might affect photic input to the
circadian system include cataract, diabetic retinopathy,
macular degeneration, retinitis pigmentosa, optic nerve
atrophy, and glaucoma.
Plausibly, cataract, defined as opacity of the crystalline
lens of the eye, does not diminish light input significantly
unless the disease is far advanced. Such might be the case
in densely Brunescent or Morgagnian cataracts [52]. Dia-
betic retinopathy, resulting from diabetes complication,
can cause severe vision loss or even blindness [53]. Dia-
betic retinal disease varies in severity; hence, light input to
the circadian system might be affected differently based
on the disease process. Certainly, an end-stage scarred ret-
ina from diabetic proliferative disease would be transmit-
ting less light input centrally. Further, a pan-retinal lasered
eye in the setting of diabetic disease has lost function in
many discrete areas, which would also reduce light stimuli
reaching the circadian system. Age-related macular degen-
eration is a disease process affecting various layers in the
deep retina with possible scarring and loss of transmission
of light stimuli [54]. This is evident from examination of
geographic atrophy and disciform scarring seen in end-
stage exudative disease. Retinitis pigmentosa is recognized
by a progressive degeneration of the rods, leading to night
blindness and loss of peripheral visual field [55]. Clinical
manifestations of this disease include pigment deposition
in the retina and attenuation of retinal blood vessels.
Finally, any optic nerve disease that is characterized by a
reduced axonal number would have a relative diminution
of transmitted stimuli compared to an eye with a normal
optic nerve.
It is of great interest to determine how these ophthalmic
diseases each affect the circadian timing system. Evidently,
since all these diseases lead to visual impairment and
worse yet blindness, they indirectly provoke physical inac-
tivity, which may cascade into sleep problems and day-
time sleepiness. Likewise, afflicted individuals would
have less opportunity for exposure to bright light expo-
sure, which may cause circadian rhythm dysfunctions
[44,56]. By contrast to the aforementioned ocular dis-
eases, the effects of glaucoma on the circadian timing sys-
tem might be twofold: 1) a direct impact through
degeneration of retinal ganglion cells and/or ocular
ischemia and reperfusion damage and 2) an indirect
impact through social isolation due to blindness, as is the
case for other ophthalmic diseases.
Available data point to glaucoma as the main ocular dis-
ease that could directly compromise light input to the cir-
cadian system. Glaucoma is an ocular degenerative
disease that affects ganglion cells, eventually causing optic
nerve dysfunction by way of axonal loss [57,58]. Reduced
axonal stimulation to the central visual pathways likely
diminishes light input to the circadian system. This is sup-
ported by recent evidence that melanopsin, which is
found in retinal ganglion cells, is a major photopigment
involved in circadian entrainment [59-61].
There are two other lines of empirical studies favoring
glaucoma as an ocular disease potentially affecting the cir-
cadian system. Ample evidence shows that intraocular
pressure, the accepted marker of glaucoma severity, exhib-
its circadian rhythmicity [62-64], which is affected by
sleep [65]. Research conducted to test the vascular theory
of glaucoma has also yielded supportive evidence linking
glaucoma to the circadian system [66]. Using novel hemo-
dynamic methods [67], investigators have shown that
reduced retinal perfusion pressure, commonly observed
in glaucoma, has a negative effect on the optic nerve head
[66,68-70], which might be particularly harmful when
occurring at night [71]. Some suggest that optic nerve vas-
cular dysregulation might be secondary to sleep apnea-
induced arterial hypertension and arteriosclerosis [72,73].
There is also preliminary data indicating that reduced ret-
inal blood flow is independently associated with the tim-
ing and mesor of aMT6s, a melatonin metabolite [74].
Circadian misalignment
Circadian misalignment refers to a mismatch between
individuals' desired bedtime and the timing of their circa-
dian system [75]. This is often observed among shift
workers and individuals suffering from jet-lag [76]. This
occurs mostly when individuals attempt to initiate sleep
at suboptimal times during their circadian cycles; conse-
quently, they may experience sleep disturbances (e.g., dif-
ficulty initiating sleep, difficulty maintaining sleep, or
early morning awakenings). Similarly, when the circadian
system becomes abnormally advanced or delayed with
respect to the desired bedtime, even individuals sleeping
at optimal times might experience similar sleep distur-
bances. This phenomenon is widely recognized as
advanced-sleep-phase syndrome or delayed-sleep-phase
syndrome [77-79].
Circadian misalignment in glaucoma: a hypothesis
In adults with healthy eyes, bright light treatment of spec-
ified intensity, wavelength, and duration is very effective
in treating circadian disorders. Among individuals withJournal of Circadian Rhythms 2008, 6:1 http://www.jcircadianrhythms.com/content/6/1/1
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varying ocular diseases, the intensity of daylight exposure
or artificial light necessary for optimal circadian entrain-
ment has not been systematically established. Moreover,
among visually impaired individuals (as may be caused
by untreated glaucoma), the consequences of circadian
misalignment have not been empirically assessed, but
available data suggest that visual and/or photic impair-
ment might cause dampened endogenous rhythms,
depression, and sleep disturbances [41,80-83].
Individuals who are blind generally experience circadian
rhythm disturbances [40,50,84], but circadian desynchro-
nization might be observable only among those with
optic diseases. A study investigating adolescents and
young adults ages 12–20 years from the Missouri School
for the Blind indicated that patients with optic diseases
showed significantly greater circadian dysfunction (e.g.,
more daytime napping and variable timing of awaken-
ing), relative to those without such diseases [85]. Another
study investigating circadian rhythms of melatonin and
body temperature of 15 patients with No Light Perception
found that 9 of those patients maintained circadian syn-
chronization, although the phase angle of entrainment
was atypical [86].
These findings are important in the sense that they sup-
port the notion that the traditional visual photoreceptors
(rods and cones), which are necessary to form visual
images, do not appear to have a primary role in circadian
entrainment. Rather, light-regulated functions – entrain-
ment of the circadian pacemaker, suppression of activity
and melatonin rhythms [87,88], and modulation of
pupillary reflex [89,90] – involve specialized signal trans-
duction mechanisms of intrinsically photosensitive reti-
nal ganglion cells [91-93]. These cells are believed to
harbor melanopsin, the primary photopigment in the
synchronization of circadian rhythms [60,94,95].
Role of melanopsin in circadian rhythms
Melanopsin is an opsin-like protein whose coding mes-
senger RNA is found in a subset of retinal ganglion cells.
These cells transduce environmental light cues and project
to the SCN via the retinohypothalamic tract [59]. Evi-
dence suggests that melanopsin cells have lower sensitiv-
ity and spatiotemporal resolution than rods and cones,
and they inherently encode ambient light intensity
[59,60]. Retinal phototransduction to the SCN is gov-
erned largely by melanopsin [59,60], although some evi-
dence continues to point to cryptochromes as key
contributors in the generation of circadian rhythms
[59,96]. Melanopsin-containing retinal ganglion cells also
receive synaptic inputs from rod and cone photoreceptors
(see Figure 1) [97,98]. Genetic ablation studies indicate
that photic input is abolished only when both melanop-
sin cells and rod/cone photoreceptors are disabled
[90,97]. Conceivably, retinal ganglion cells respond to
light input via a melanopsin-based signaling pathway and
via a synaptic cascade triggered by rod and cone photore-
ceptors.
The SCN transmit the retinal signal indirectly to pinealo-
cytes, which in turn transform it into a neuroendocrine
message that synchronizes important physiologic and
behavioral processes to a 24-hour day [8,88]. Notwith-
standing its importance in circadian rhythmicity, evidence
is lacking with regard to melanopsin's absorbance spec-
trum, which may be shorter than spectra established from
behavioral and electrophysiological studies. One estimate
suggested that melanopsin was most efficiently excited by
blue light (420–440 nm) [99].
The melanopsin-containing retinal ganglion cells are
widely distributed in the peripheral retina, with dendrites
spreading throughout the retina, as might be expected of
an illumination-measurement system. Using a melanop-
sin antibody and/or cRNA probes in combination with
PACAP immunostaining, colocalization studies indicated
that melanopsin is located exclusively in the PACAP-con-
Illustration of ocular photic transmission pathway Figure 1
Illustration of ocular photic transmission pathway. As 
light enters the eyes, it is absorbed by photopigments in 
either the rods or cones in the photoreceptive field (PR), 
which convert it into a voltage signal. The signal triggers a 
cascade of synaptic activities through activation of second-
order neurons: horizontal cell (HC), bipolar cells (BC), and 
amacrine cells (AC), some having excitatory action and oth-
ers inhibitory. The ganglion cells, referred to as third-order 
neurons, then carry photic input all the way to the thalamus, 
projecting either to the suprachiasmatic nuclei (SCN) or the 
lateral geniculate nucleus (LGN). A subset of intrinsically 
photoresponsive retinal ganglion cells (ipRGCs), expressing 
melanopsin and cryptochromes, feed the circadian system.Journal of Circadian Rhythms 2008, 6:1 http://www.jcircadianrhythms.com/content/6/1/1
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taining retinal ganglion cells on the surface of soma and
dendrites [100]. They are expressed in the majority of ret-
inal ganglion cells projecting to the SCN, ventral subpar-
aventricular zone, and ventrolateral preoptic nucleus as
well as in a subpopulation of retinal ganglion cells inner-
vating the pretectal area and the intergeniculate leaflet,
through which light has secondary access to the SCN.
It is estimated that two-thirds of retinal ganglion cells con-
taining melanopsin transcript project to the SCN and con-
tralateral pretectal area, and one-fifth projects to the
ipsilateral intergeniculate leaflet [101]. According to one
study mice that are melanopsin deficient seemed to
exhibit complete loss of photo-entrainment of the SCN
[102]. Melanopsin activates the photoreceptor G-protein,
transducing, in a light-dependent manner, and it is not
concentrated in the macula [99]. Accordingly, the periph-
eral ganglion cell damage noted in glaucoma might be
particularly harmful to the retinohypothalamic melanop-
sin cells.
The evidence summarized above supports the notion that,
in mammals, the functionality of photoreception is two-
fold: one associated with creating a detailed visual image
of the environment and another involving the photic reg-
ulation of temporal or circadian biology [103]. While
understanding the intricacies of these associations await
further investigation, there is a body of research evidenc-
ing that abnormalities of the circadian timing system may
be directly related to depressive symptoms and circadian
dysregulations [5,104]. Misalignment of the circadian
pacemaker, expressed either as delayed sleep phase syn-
drome or advanced sleep phase syndrome, or depression
and insomnia may be caused by inadequate exposure to
day/light cycles or by ophthalmic disease that reduce light
signal transmission, or both.
Glaucoma and melanopsin cells
One might conjecture that glaucomatous retinopathies
could predispose individuals to develop circadian mis-
alignment, since ganglion cell damage in glaucoma might
result in melanopsin cell death. Glaucoma represents the
principal ophthalmic disorder to explore whether in fact
light transmission to the SCN is compromised as a result
of melanopsin cell loss. In fact, a recent study using in-situ
hybridization and immunocytochemistry to study 17
human eyes and hypothalami containing the SCN, found
an even distribution of melanopsin in the retina [105].
Equally important were the finding of reduced retinal gan-
glion cells in two patients with glaucoma and the observa-
tion that melanopsin was conserved in retinae of blind
patients with degeneration of the outer and/or inner lay-
ers. Evidently, these findings should be replicated in large-
scale studies before definitive conclusions can be reached.
Likewise, future comparative studies should investigate
whether individuals with other retinal diseases (e.g., retin-
itis pigmentosa) would also show reduced retinal gan-
glion cells.
We should note that data from animal studies are much
less consistent. In the macaque monkey with experimen-
tally induced glaucoma, loss of retinal ganglion cells
results in the abolishment of the scotopic threshold
response using corneal flash electroretinograms [106].
Investigators made a similar observation after they
induced retinal ganglion cell death through transection of
the optic nerve of rats [107]. Even when mutant mice were
able to generate scotopic threshold response, they were
unable to maintain photoentrainment without the pres-
ence of retinal ganglion cells [108]. On balance, another
animal study suggests that melanopsin-expressing retinal
ganglion cells might be less susceptible to death after
induction of chronic ocular hypertension [109]. Seem-
ingly, loss of retinal ganglion cells leads to responses that
are species specific.
Considering the relatively high prevalence of ophthalmic
diseases [57,58,110] in aging Americans, it is important to
study the link of ophthalmic dysfunction to circadian
rhythm dysfunctions [57,58,110]. If indeed impairment
of the photic pathway is linked to certain type of sleep dis-
turbances and depression, individuals from the Black race
might be at higher risks for depressed mood and disturbed
sleep related to aging eyes. Glaucoma, for instance, is
more prevalent among Blacks (see Figure 2) [58,110], and
ambient light data have shown reduced illumination
among Black men and women, compared to their White
counterparts [44]. This may lead to renewed effort for
Percentage of older adults with glaucoma Figure 2
Percentage of older adults with glaucoma. Notice that 
the ethnic difference in glaucoma for both men and women 
widened between 1984 and 1995. Data originated from the 
U.S. Centers for Disease Control and Prevention.Journal of Circadian Rhythms 2008, 6:1 http://www.jcircadianrhythms.com/content/6/1/1
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early detection of glaucoma, as treatment will not only
halt further optic nerve damage but also may help pre-
serve circadian photo-entrainment.
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